01493nas 2200457-a 450 99621305670331620180709065456.21545-3790(OCoLC)52513782(CKB)111086803898000(CONSER)--2003213342(EXLCZ)9911108680389800020030627a20029999 s-- aengurcnu||||||||txtrdacontentcrdamediacrrdacarrier91st meridianIowa City, Iowa University of Iowa, International Writing Program©2001-Title from journal home page (University of Iowa, viewed June 26, 2003).Ninety-first meridian91st meridianLiterature, Modern20th centuryPeriodicalsPoetry, Modern20th centuryPeriodicalsPoetry, Modern20th centuryTranslations into EnglishPeriodicalsLiterature, Modernfast(OCoLC)fst01000172Poetry, Modernfast(OCoLC)fst01067769Periodicals.fastTranslations.fastLiterature, ModernPoetry, ModernPoetry, ModernLiterature, Modern.Poetry, Modern.808University of Iowa.International Writing Program.JOURNAL99621305670331691st meridian2100629UNISA04131nam 2200961z- 450 991074326990332120230911(CKB)5690000000228609(oapen)doab113979(EXLCZ)99569000000022860920230920c2023uuuu -u- -engurmn|---annantxtrdacontentcrdamediacrrdacarrierGlutathione: Chemistry and BiochemistryMDPI - Multidisciplinary Digital Publishing Institute20231 online resource (212 p.)3-0365-8666-0 It has been known that cellular glutathione content and its speciation play a role, among others, in redox homeostasis, cell cycle control, immunological defense, and pathological abnormalities. Furthermore, it plays a significant role in the biotransformation of drugs and other endogenous or exogenous electrophilic species. Most of these cellular functions are related to the thiol function of the cysteine moiety.This reprint presents the publications that appeared in the Special Issue of Molecules, "Glutathione: Chemistry and Biochemistry." The first three contributions review the present-day knowledge of the GSH/GSSG system and the most important GSH-related proteins involved in regulating various cellular events. The subsequent four contributions present selected interventions that modulate the GSSG/2GSH system. One of the contributions to this session describes a new HPLC method to quantify the reduced and oxidized glutathione levels. The third session involves three contributions demonstrating the role of GSH in the metabolism of different candidate and clinically used anticancer drugs. One of the contributions, a theoretical work, provides helpful information for developing GSH analogs with high ACE inhibitor activity.By purpose and content, this Special Issue is addressed to the vast number of life science researchers (academic and industrial) and medical professionals who are interested in or already engaged in research that involves glutathione.GlutathioneBiology, life sciencesbicsscResearch and information: generalbicsscangiotensin-converting enzymeanticancer drugsapoptosisautoimmune diseasesbioactivationbraincellcell injurychalconecyclophosphamidecysteinedetoxificationDFTdiastereoselective additiondiode array detectorendothelial cellsfluorescence probesGCLcglutaredoxinglutathioneglutathione enzymeglutathione systemglutathione-S-transferaseglutathionylationGSHGSSGSSGironiron-sulfur clusterischemialiquid chromatographyM06-2X/6-311++G(d,p)mechanisms of glutathione conjugation reactionMichael additionmolecular dockingn/ananotoxicitynitrosoglutathioneoxidative stresspharmacokineticsphysicochemical propertiespolymerized whey proteinpolymorphismreactive oxygen speciesredox homeostasisredox potentialredox-regulationS-glutathionylationS-nitrosylationsulodexidesupramolecular arrangementthiolstoxicityBiology, life sciencesResearch and information: generalBOOK9910743269903321Glutathione: Chemistry and Biochemistry3560498UNINA04019nam 2201045z- 450 991059507940332120220916(CKB)5680000000080731(oapen)https://directory.doabooks.org/handle/20.500.12854/92076(oapen)doab92076(EXLCZ)99568000000008073120202209d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierEnhancing Mesenchymal Stem Cells (MSCs) for Therapeutic PurposesBasel20221 online resource (204 p.)3-0365-4996-X 3-0365-4995-1 The regenerative and immunomodulatory properties of mesenchymal stem cells (MSCs) have made these cells the focus of multiple pre-clinical studies and clinical trials. While the results from these clinical studies have established that MSCs are safe, the efficacy of these cells is not as well-established. In this regard, there have been increased efforts towards generating potentiated/activated MSCs with enhanced therapeutic efficacy. Research on the mechanisms for enhancing MSC potency and efficacy is an area of active study with great potential for translation into clinical settings. The purpose of this book is to bring together recent research from a broad range of topics relating to potentiation strategies for enhancing MSC therapeutic efficacy, including growth factor pre-conditioning, hypoxia, and 3D culture. The research compiled in this book increases the basic understanding of MSC culture techniques and describes some MSC preparations for potential novel therapeutic applications.Enhancing Mesenchymal Stem Cells Medicine and Nursingbicssc3-methyladenine3D cultureadipose tissue-derived stem cells (ASCs)adipose-derived stem cellAKB-6548angiogenesisastrocytesautophagyaxon growthCD206cell therapychemotaxiscombination therapyengineered cardiac patchesexosomefibroblast growth factor 2hepatocyte growth factorhypoxiaIFN-γimmunomodulationimmunosuppressioniMSC secretomeinflammationiPSC-derived MSCsliver cirrhosismacrophagesmalignant pleural mesothelioma (MPM)mesenchymal stem cellsmesenchymal stromal cellsmesotheliomananofiber-hydrogel compositeneuralneuroprotectionneurospheresosteogenic differentiationoxygen conditionsparacrine potentialphagocytosisplacenta-derived mesenchymal stem cellspluripotencypolyunsaturated fatty acidpotentiation of iMSC efficacypre-conditioningpreconditioningprimingquiescencerapamycinsecondary injurysecretomesecretory profilespheroidsspinal cord injuryumbilical cordVadadustatWharton's jelly mesenchymal stem cellsWKYMVmMedicine and NursingYlostalo Joni Hedt1289237Durand Nisha CedtYlostalo Joni HothDurand Nisha CothBOOK9910595079403321Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes3030230UNINA02399nas 2200673-a 450 991014600790332120260218111555.01718-4304(DE-599)ZDB2075957-5(CKB)954925560567(CONSER)sn-88000192-(DE-599)2075957-5(EXLCZ)9995492556056719880106a19889999 --- aengtxtrdacontentcrdamediacrrdacarrierPeritoneal dialysis international journal of the International Society for Peritoneal DialysisNew York Pergamon Press©1988-Milton, ON Multimed IncLondon SAGE Publications1 online resourceRefereed/Peer-reviewedTitle from cover.Volumes for 1988- include abstracts of the 8th- annual CAPD conference, 1988-Issues for v. 10, no. 4 (1990)--published: Toronto : Multimed Inc.Print version: Peritoneal dialysis international : 0896-8608 (DLC)sn 88000192 (OCoLC)17309238 PDIPERIT DIAL INTPERITON DIALYSIS INTPERIT DIA IPERIT. DIAL. INTPerit. dial. int.Peritoneal dialysisPeriodicalsContinuous ambulatory peritoneal dialysisPeriodicalsPeritoneal DialysisPeritoneal Dialysis, Continuous AmbulatoryContinuous ambulatory peritoneal dialysisfast(OCoLC)fst00876757Peritoneal dialysisfast(OCoLC)fst01058200Peritoneale dialysegttConference Proceedings.Periodical.Periodicals.fastPeriodicals.lcgftPeritoneal dialysisContinuous ambulatory peritoneal dialysisPeritoneal Dialysis.Peritoneal Dialysis, Continuous Ambulatory.Continuous ambulatory peritoneal dialysis.Peritoneal dialysis.Peritoneale dialyse.617International Society for Peritoneal Dialysis.JOURNAL9910146007903321exl_impl conversionPeritoneal dialysis international2564381UNINA